Cerebral Embolic Protection during Transcatheter Aortic-Valve Replacement.

Samir R KapadiaRaj MakkarMartin LeonMohamed Abdel-WahabThomas WaggonerSteffen MassbergWolfgang RottbauerSamuel HorrLars SondergaardJuhana KarhaRobert GooleyLowell SatlerRobert C StolerSteven R MesséSuzanne J BaronJulia SeegerSusheel KodaliAmar KrishnaswamyVinod H ThouraniKatherine HarringtonStuart PocockRodrigo ModoloDominic J AlloccoIan T MeredithAxel Linkenull null

Published in: The New England journal of medicine (2022)

Among patients with aortic stenosis undergoing transfemoral TAVR, the use of CEP did not have a significant effect on the incidence of periprocedural stroke, but on the basis of the 95% confidence interval around this outcome, the results may not rule out a benefit of CEP during TAVR. (Funded by Boston Scientific; PROTECTED TAVR ClinicalTrials.gov number, NCT04149535.).

Keyphrases

transcatheter aortic valve replacement
aortic stenosis
aortic valve
aortic valve replacement
transcatheter aortic valve implantation
atrial fibrillation
risk factors
percutaneous coronary intervention
subarachnoid hemorrhage
ejection fraction
direct oral anticoagulants
left ventricular
acute coronary syndrome